Hims & Hers Health (HIMS) | Financial Analysis & Statements
Hims & Hers Health, Inc. Mid-cap Consumer Defensive
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
617.8M
Gross Profit
444.4M
71.94%
Operating Income
9.2M
1.49%
Net Income
20.6M
3.33%
EPS (Diluted)
$0.08
Balance Sheet Metrics
Total Assets
2.2B
Total Liabilities
1.6B
Shareholders Equity
540.9M
Debt to Equity
2.98
Cash Flow Metrics
Operating Cash Flow
65.8M
Free Cash Flow
-2.6M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Hims & Hers Health Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 2.3B | 1.5B | 872.0M | 526.9M | 271.9M |
| Cost of Goods Sold | 614.3M | 303.4M | 157.1M | 118.2M | 67.4M |
| Gross Profit | 1.7B | 1.2B | 714.9M | 408.7M | 204.5M |
| Gross Margin % | 73.8% | 79.5% | 82.0% | 77.6% | 75.2% |
| Operating Expenses | |||||
| Research & Development | 149.3M | 78.8M | 48.2M | 29.2M | 22.4M |
| Selling, General & Administrative | 1.2B | 846.6M | 576.3M | 370.8M | 249.6M |
| Other Operating Expenses | 286.4M | 185.8M | 119.9M | 77.4M | 47.6M |
| Total Operating Expenses | 1.6B | 1.1B | 744.4M | 477.4M | 319.5M |
| Operating Income | 105.6M | 61.9M | -29.5M | -68.7M | -115.0M |
| Operating Margin % | 4.5% | 4.2% | -3.4% | -13.0% | -42.3% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | - | - | - | - | 0 |
| Other Non-Operating Income | 18.3M | 9.8M | 7.9M | 3.0M | 4.2M |
| Pre-tax Income | 123.9M | 71.7M | -21.6M | -65.7M | -110.8M |
| Income Tax | -4.4M | -54.3M | 2.0M | -31.0K | -3.1M |
| Effective Tax Rate % | -3.6% | -75.8% | 0.0% | 0.0% | 0.0% |
| Net Income | 128.4M | 126.0M | -23.5M | -65.7M | -107.7M |
| Net Margin % | 5.5% | 8.5% | -2.7% | -12.5% | -39.6% |
| Key Metrics | |||||
| EBITDA | 155.7M | 79.0M | -19.9M | -61.2M | -111.0M |
| EPS (Basic) | $0.57 | $0.58 | $-0.11 | $-0.32 | $-0.58 |
| EPS (Diluted) | $0.51 | $0.53 | $-0.11 | $-0.32 | $-0.58 |
| Basic Shares Outstanding | 224959268 | 215939037 | 209344712 | 204516120 | 186781537 |
| Diluted Shares Outstanding | 224959268 | 215939037 | 209344712 | 204516120 | 186781537 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Hims & Hers Health Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 228.6M | 220.6M | 96.7M | 46.8M | 71.8M |
| Short-term Investments | 348.9M | 79.7M | 124.3M | 132.9M | 175.5M |
| Accounts Receivable | 32.1M | 6.1M | 5.7M | 3.2M | 3.6M |
| Inventory | 80.1M | 64.4M | 22.5M | 21.6M | 13.6M |
| Other Current Assets | 4.4M | 8.9M | 5.2M | 1.8M | 890.0K |
| Total Current Assets | 767.6M | 395.8M | 265.1M | 216.6M | 269.9M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 351.3M | 44.6M | 24.5M | 6.6M | 5.1M |
| Goodwill | 752.8M | 268.9M | 240.3M | 243.6M | 247.7M |
| Intangible Assets | 196.1M | 43.4M | 18.6M | 21.8M | 25.9M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 112.4M | 62.6M | 947.0K | 889.0K | 8.8M |
| Total Non-Current Assets | 1.4B | 311.7M | 176.1M | 149.7M | 150.7M |
| Total Assets | 2.2B | 707.5M | 441.2M | 366.3M | 420.6M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 143.3M | 91.2M | 43.1M | 32.4M | 19.6M |
| Short-term Debt | 4.8M | 1.9M | 1.3M | 1.7M | 1.4M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 3.6M | - | - | - | - |
| Total Current Liabilities | 404.4M | 221.4M | 88.5M | 47.9M | 79.2M |
| Non-Current Liabilities | |||||
| Long-term Debt | 1.1B | 9.5M | 8.7M | 3.6M | 4.1M |
| Deferred Tax Liabilities | 28.9M | - | - | - | - |
| Other Non-Current Liabilities | 64.7M | - | 22.0K | 3.0M | 2.6M |
| Total Non-Current Liabilities | 1.2B | 9.5M | 8.7M | 6.7M | 6.7M |
| Total Liabilities | 1.6B | 230.8M | 97.2M | 54.6M | 86.0M |
| Equity | |||||
| Common Stock | 23.0K | 22.0K | 21.0K | 21.0K | 20.0K |
| Retained Earnings | -113.8M | -242.1M | -368.2M | -344.6M | -279.0M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 540.9M | 476.7M | 344.0M | 311.7M | 334.6M |
| Key Metrics | |||||
| Total Debt | 1.1B | 11.3M | 9.9M | 5.3M | 5.5M |
| Working Capital | 363.2M | 174.5M | 176.6M | 168.7M | 190.7M |
Balance Sheet Composition
Hims & Hers Health Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 128.4M | 126.0M | -23.5M | -65.7M | -107.7M |
| Depreciation & Amortization | 54.5M | 17.1M | 9.5M | 7.5M | 4.1M |
| Stock-Based Compensation | 135.2M | 92.3M | 66.1M | 42.8M | 67.2M |
| Working Capital Changes | 65.7M | 67.2M | 10.7M | 1.4M | 58.0K |
| Operating Cash Flow | 400.9M | 243.9M | 68.6M | -12.2M | -40.1M |
| Investing Activities | |||||
| Capital Expenditures | -226.0M | -41.7M | -17.2M | -2.7M | -832.0K |
| Acquisitions | -145.2M | -15.4M | 0 | -459.0K | -46.5M |
| Investment Purchases | -745.8M | -160.6M | -157.2M | -187.7M | -266.6M |
| Investment Sales | 108.7M | 209.7M | 171.6M | 230.1M | 161.8M |
| Investing Cash Flow | -1.0B | -8.0M | -2.8M | 39.2M | -152.1M |
| Financing Activities | |||||
| Share Repurchases | -90.0M | -83.0M | -2.0M | 0 | -22.0M |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 970.0M | - | 0 | 0 | 1.2M |
| Debt Repayment | - | - | - | 0 | 0 |
| Financing Cash Flow | 712.1M | -138.7M | -16.1M | -36.6M | 233.0M |
| Free Cash Flow | 57.4M | 198.3M | 47.0M | -33.8M | -39.4M |
| Net Change in Cash | 104.6M | 97.2M | 49.7M | -9.5M | 40.8M |
Cash Flow Trend
Hims & Hers Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
55.20
Forward P/E
19.83
Price to Book
11.83
Price to Sales
2.73
PEG Ratio
-2.21
Profitability Ratios
Profit Margin
5.47%
Operating Margin
2.72%
Return on Equity
25.23%
Return on Assets
5.29%
Financial Health
Current Ratio
1.90
Debt to Equity
207.16
Beta
2.32
Per Share Data
EPS (TTM)
$0.51
Book Value per Share
$2.38
Revenue per Share
$10.44
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| HIMS | 6.4B | 55.20 | 11.83 | 25.23% | 5.47% | 207.16 |
| Procter & Gamble | 340.5B | 21.55 | 6.48 | 31.56% | 19.30% | 68.72 |
| Colgate-Palmolive | 67.9B | 31.83 | 1,249.55 | 497.47% | 10.46% | 2,343.56 |
| E.l.f. Beauty | 4.0B | 37.84 | 15.04 | -0.29% | -0.23% | 79.71 |
| Interparfums | 2.9B | 18.17 | 3.47 | 20.34% | 11.31% | 18.82 |
| Coty | 2.1B | 37.39 | 0.57 | -12.59% | -9.13% | 82.74 |
Financial data is updated regularly. All figures are in the company's reporting currency.






